m6A-Targeted Cancer Therapy: Molecular Targets, Inhibitors, and Nanodelivery Strategies
Chenyu Li, Yuan Guo, Wenjun Jiang, Wei Xie, Yao Yao · 2026
Read m6A-Targeted Cancer Therapy: Molecular Targets, Inhibitors, and Nanodelivery Strategies by Chenyu Li, Yuan Guo, Wenjun Jiang, Wei Xie, Yao Yao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13584959.txt.
Description
Li, Guo, Jiang, Xie, and Yao published in twenty twenty-six a review of cancer therapy aimed at a common RNA mark called m6A. Cells add this chemical mark to RNA to control how genes are used. The mark affects RNA stability, protein making, and breakdown. In cancer, it can raise or lower key transcripts and help tumors grow. Blocking the machinery behind the mark is a rising treatment idea.
The review covers small drug blockers and RNA-based tools aimed at m6A regulators. It also covers tiny carriers that ferry drugs to tumors more safely. Lipid particles, polymers, and cell vesicles all feature as carriers. Early lab results look promising, but clinical use remains limited. Drug precision and delivery still need much work.
Catalog record
| CREATOR | Chenyu Li, Yuan Guo, Wenjun Jiang, Wei Xie, Yao Yao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |